Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis
- 1 September 2005
- journal article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 5 (9) , 530-531
- https://doi.org/10.1016/s1473-3099(05)70197-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trialThe Lancet, 2004
- British Society for Medical Mycology proposed standards of care for patients with invasive fungal infectionsThe Lancet Infectious Diseases, 2003
- Cryptococcal infection in a cohort of HIV-1-infected Ugandan adultsAIDS, 2002
- Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency VirusClinical Infectious Diseases, 2002
- Clinical Presentation and Risk Behaviors of Patients with Acquired Immunodeficiency Syndrome in Thailand, 1994-1998: Regional Variation and Temporal TrendsClinical Infectious Diseases, 2001
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1997
- Fluconazole Compared with Amphotericin B plus Flucytosine for Cryptococcal Meningitis in AIDSAnnals of Internal Medicine, 1990